Founded in 2004, Guangzhou Osungda Medical Device Technology Co., Ltd. is the pioneer of China's medical device CRO industry and the country's first one-stop comprehensive medical device CXO platform. The company has recently completed a RMB 100 million Series D financing round, with Lishui Green Valley Talent Osungda New Fund as the sole investor. The proceeds will be primarily allocated to the construction of the headquarters MAH mass production facility, the provincial-level medical device proof-of-concept center and pilot workshop, the development of a global medical device AI digital-intelligent innovation platform, as well as the R&D and application of vertical large models for the medical device industry and industrial AI agents. Over the 22 years since its founding, Osungda has served more than 5,000 medical device professional clients worldwide, cumulatively transformed over 3,600 new medical devices, established an integrated CRDMO platform covering the entire lifecycle of medical devices, and pioneered related service models. At present, the company is driven by a dual-wheel strategy of "industrial innovation + industrial AI," leveraging self-developed vertical large models for medical devices to build a full-industry digital-intelligent ecosystem, improve the success rate of medical device innovation from laboratory to commercialization, and reduce time and overall costs. The investor and the founder of Osungda each made statements regarding this financing and the company's subsequent development. Looking ahead, Osungda will build an early-stage ecosystem, support more source innovation, and help promote the high-quality development of China's medical device industry.